BANK OF AMERICA CORP /DE/ - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 97 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$119,776
+398.3%
64,052
+568.9%
0.00%
Q2 2023$24,036
-15.9%
9,576
-41.3%
0.00%
Q1 2023$28,570
-24.9%
16,326
+82.4%
0.00%
Q4 2022$38,046
+1802.3%
8,952
+431.6%
0.00%
Q3 2022$2,0001,684
+717.5%
0.00%
Q2 2022$0
-100.0%
206
-97.9%
0.00%
Q1 2022$24,000
-53.8%
9,794
-49.3%
0.00%
Q4 2021$52,000
-8.8%
19,311
+68.0%
0.00%
Q3 2021$57,000
-12.3%
11,493
+32.3%
0.00%
Q2 2021$65,000
-73.8%
8,690
-79.4%
0.00%
Q1 2021$248,000
+406.1%
42,262
+306.8%
0.00%
Q4 2020$49,000
+390.0%
10,390
+246.3%
0.00%
Q3 2020$10,0003,0000.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders